Recombinant Anti-CD55 x Anti-CA9 Bispecific Antibody (Fab-IgG) (FABIG-123)

Recombinant Anti-CD55 x Anti-CA9 Bispecific Antibody (Fab-IgG) is designed to be expressed as three chains, assembling in vivo and resulting in the construct of Fab-IgG (Tandem Fab-Fc). Fab-IgG has standard Fab and Fc domains, with no mutations, which may permit it has similar affinity binding and PK profile comparable to the parental antibodies. This BsAb can recruit complements to tumor cells. It is designed for the research of Renal cell cancer (RCC); Solid tumors therapy.

Datasheet INQUIRY

Specifications

Targets

CD55 & CA9

Type

Fab-IgG

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Renal cell cancer (RCC); Solid tumors

Targets

Target 1

CD55

Gene ID

1604

UniProt ID

P08174

Alternative Names

CD55; CD55 molecule, decay accelerating factor for complement (Cromer blood group); CR; TC; DAF; CROM; complement decay-accelerating factor; CD55 antigen

Target 2

CA9

Gene ID

768

UniProt ID

Q16790

Alternative Names

CA9; carbonic anhydrase 9; RCC-associated antigen G250; G250; CA-IX; carbonic anhydrase IX; MN; CAH9

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD55 x Anti-CA9 Bispecific Antibody (Fab-IgG) (FABIG-123). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-CD55 x Anti-CA9 Bispecific Antibody (Fab-IgG) (CAT#: FABIG-123)

Specifications

Targets

Customer Reviews and Q&As